atracurium has been researched along with Amyotonia Congenita in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cao, M; Huang, H; Liao, Y; Ou, Y; Tong, J | 1 |
Dmitrovic, P; Ida, KK; Sandersen, C; Tutunaru, A; Van Wijnsberghe, AS | 1 |
Bourgain, JL; Motamed, C | 1 |
Rosenberg, SG | 1 |
Champion, H; Frankel, H; Jeng, J; St Andre, A; Tilly, E | 1 |
Breningstall, GN; Engel, AG; Fugate, JH; Kurachek, SC | 1 |
1 trial(s) available for atracurium and Amyotonia Congenita
Article | Year |
---|---|
Optimal dose of neostigmine antagonizing cisatracurium-induced shallow neuromuscular block in elderly patients: a randomized control study.
Topics: Aged; Atracurium; Cholinesterase Inhibitors; Delayed Emergence from Anesthesia; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Postoperative Nausea and Vomiting | 2023 |
5 other study(ies) available for atracurium and Amyotonia Congenita
Article | Year |
---|---|
Neuromuscular blockade effects of cisatracurium in 11 cats undergoing ophthalmological surgery anaesthetised with isoflurane.
Topics: Anesthetics; Animals; Atracurium; Cat Diseases; Cats; Isoflurane; Neuromuscular Blockade; Neuromuscular Diseases; Retrospective Studies | 2022 |
[Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants].
Topics: Adult; Aged; Anesthesia Recovery Period; Atracurium; Electric Stimulation; Electrodiagnosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Intraoperative; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Program Evaluation; Quality Assurance, Health Care; Synaptic Transmission | 2009 |
Atracurium and prolonged muscle weakness.
Topics: Atracurium; Female; Humans; Middle Aged; Muscles; Neuromuscular Diseases; Paresis | 1994 |
The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
Topics: Aged; Atracurium; Cost-Benefit Analysis; Critical Care; Drug Therapy; Electrolytes; Female; Humans; Incidence; Male; Middle Aged; Monitoring, Physiologic; Muscle Contraction; Muscle, Skeletal; Neuromuscular Diseases; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Paralysis; Prospective Studies; Rehabilitation; Respiration, Artificial; Retrospective Studies; Risk Factors; Thumb; Vecuronium Bromide | 1996 |
Treatment of congenital endplate acetylcholinesterase deficiency by neuromuscular blockade.
Topics: Acetylcholinesterase; Atracurium; Humans; Infant; Male; Neuromuscular Diseases; Neuromuscular Nondepolarizing Agents | 1996 |